Hepatitis C Vaccine Delivered By Inovio Biomedical’s Electroporation System Shows Increased T-Cell Responses And … (Medical News Today)

Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported additional interim results from its ongoing phase I/II clinical study of its ChronVac-C® therapeutic DNA vaccine, which is delivered using Inovio’s electroporation-based DNA delivery system.

Tagged as: Amex, C Vaccine, Cell Responses, Delivery System, Dna Vaccine, Dna Vaccines, Electroporation System, Hepatitis, Hepatitis C, Hepatitis Vaccine, Ino, Interim Results, Medical News, News Corporation, News Today, T Cell, Tripep